Amalgent is a fixed-dose combination therapeutics company developing alternatives to traditional opioid pain medications. The Company is developing combination products the provide effective analgesia at dramatically reduced doses. By reducing the dose, Amalgent's products minimize side effects like respiratory depression, confusion, constipation and addiction.
Location: United States, North Carolina, Greenville
Employees: 1-10
Total raised: $250K
Founded date: 2020
Investors 1
| Date | Name | Website |
| 19.02.2025 | The Innova... | innovation... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.02.2023 | - | $250K | - |
Mentions in press and media 1
| Date | Title | Description |
| - | Amalgent Therapeutics | “Repurposing Existing Drugs to Make Pain Relief Safer ” |